The Concise Guide to PHARMACOLOGY 2015/16: Ligand‐gated ion channels

The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands ( www.guidetopharmacology.org ), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13349/full . Ligand‐gated ion channels are one of the eight major pharmacological targets into which the Guide is divided, with the others being: ligand‐gated ion channels, voltage‐gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The Concise Guide is published in landscape format in order to facilitate comparison of related targets. It is a condensed version of material contemporary to late 2015, which is presented in greater detail and constantly updated on the website www.guidetopharmacology.org , superseding data presented in the previous Guides to Receptors & Channels and the Concise Guide to PHARMACOLOGY 2013/14. It is produced in conjunction with NC‐IUPHAR and provides the official IUPHAR classification and nomenclature for human drug targets, where appropriate. It consolidates information previously curated and displayed separately in IUPHAR‐DB and GRAC and provides a permanent, citable, point‐in‐time record that will survive database updates.

[1]  Graham L. Collingridge,et al.  A nomenclature for ligand-gated ion channels , 2009, Neuropharmacology.

[2]  Filip Van Petegem,et al.  Function Ryanodine Receptors : Structure and Minireviews : , 2012 .

[3]  H. Tse,et al.  Glutamate receptor ion channels : Activators and inhibitors , 2000 .

[4]  Ernst Niggli,et al.  Posttranslational modifications of cardiac ryanodine receptors: Ca(2+) signaling and EC-coupling. , 2013, Biochimica et biophysica acta.

[5]  A. Marks,et al.  Ryanodine receptor channelopathies , 2010, Pflügers Archiv - European Journal of Physiology.

[6]  G. Grisetti,et al.  Further Reading , 1984, IEEE Spectrum.

[7]  M. Periasamy,et al.  Functional interaction between calsequestrin and ryanodine receptor in the heart , 2012, Cellular and Molecular Life Sciences.

[8]  S. Cull-Candy,et al.  Role of Distinct NMDA Receptor Subtypes at Central Synapses , 2004, Science's STKE.

[9]  Baljit S. Khakh,et al.  Neuromodulation by Extracellular ATP and P2X Receptors in the CNS , 2012, Neuron.

[10]  B S Khakh,et al.  International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. , 2001, Pharmacological reviews.

[11]  Laricia Bragg,et al.  P2X receptor channels show three-fold symmetry in ionic charge selectivity and unitary conductance , 2010, Nature Neuroscience.

[12]  Michael F. Jarvis,et al.  ISSUE IN MEMORY OF AVRAM GOLDSTEIN P 2 X Receptors as Drug Targets , 2013 .

[13]  D. Macmillan,et al.  FK506 binding proteins: cellular regulators of intracellular Ca2+ signalling. , 2013, European journal of pharmacology.

[14]  X. Wehrens,et al.  Ryanodine receptor phosphorylation, calcium/calmodulin-dependent protein kinase II, and life-threatening ventricular arrhythmias. , 2011, Trends in cardiovascular medicine.

[15]  Annette Nicke,et al.  Molecular and functional properties of P2X receptors—recent progress and persisting challenges , 2012, Purinergic Signalling.

[16]  Stanko S. Stojilkovic,et al.  Activation and Regulation of Purinergic P2X Receptor Channels , 2011, Pharmacological Reviews.

[17]  Christopher Southan,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand‐gated ion channels , 2017, British journal of pharmacology.

[18]  A. Marks,et al.  Ryanodine receptor studies using genetically engineered mice , 2010, FEBS letters.